Nagamata Satoshi, Nakasuji Yukiko, Yamanaka Keitaro, Azumi Maho, Washio Keiichi, Shimizu Maho, Takahashi Ryosuke, Matsumoto Kazuyo, Murata Yuka, Suzuki Kaho, Deguchi Masashi, Yamada Hideto, Terai Yoshito
Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Department of Obstetrics and Gynecology, National Hospital Organization Kobe Medical Center, 3-1-1 Nishiochiai, Suma-ku, Kobe, Hyogo 654-0155, Japan.
Case Rep Obstet Gynecol. 2020 Aug 10;2020:9106390. doi: 10.1155/2020/9106390. eCollection 2020.
Primary peritoneal carcinosarcomas which arise from extragenital locations are extremely rare. Carinosarcomas contain both carcinomatous and sarcomatous elements and can be mainly detected in the female genital tract. We herein report a case of primary peritoneal carcinosarcoma diagnosed by laparoscopic surgery and treated with olaparib. A 62-year-old woman referred to our hospital due to abdominal distension. From imaging findings, we suspected advanced primary peritoneal carcinoma, and laparoscopic surgery was thereafter performed. The pathological diagnosis was carcinosarcoma, and the patient received chemotherapy with docetaxel and carboplatin. After three cycles of chemotherapy, the interval debulking surgery was attempted but resulted in suboptimal results. Because the bilateral ovaries were observed with a normal size and normal findings, we considered that the most likely diagnosis was primary peritoneal carcinosarcoma. After the additional chemotherapy and a 6-month observation period, the tumor relapsed. The patient received chemotherapy again, and the peritoneal carcinosarcoma was judged to be a platinum-sensitive tumor. Oral administration of olaparib was thus initiated. Although a dose reduction was needed due to anemia, olaparib was effective, and the patient could continue the drug for another 7 months. This is the first report of primary peritoneal carcinosarcoma treated with olaparib and shows that it could be a treatment option for platinum-sensitive tumors.
起源于生殖器外部位的原发性腹膜癌肉瘤极为罕见。癌肉瘤同时包含癌性和肉瘤性成分,主要见于女性生殖道。我们在此报告一例经腹腔镜手术诊断并接受奥拉帕利治疗的原发性腹膜癌肉瘤病例。一名62岁女性因腹胀前来我院就诊。根据影像学检查结果,我们怀疑为晚期原发性腹膜癌,随后进行了腹腔镜手术。病理诊断为癌肉瘤,患者接受了多西他赛和卡铂化疗。化疗三个周期后,尝试进行间隔减瘤手术,但效果不理想。由于双侧卵巢大小和检查结果正常,我们认为最可能的诊断是原发性腹膜癌肉瘤。在追加化疗和6个月的观察期后,肿瘤复发。患者再次接受化疗,腹膜癌肉瘤被判定为铂敏感肿瘤。因此开始口服奥拉帕利。尽管因贫血需要减量,但奥拉帕利有效,患者能够继续用药7个月。这是首例用奥拉帕利治疗原发性腹膜癌肉瘤的报告,表明它可能是铂敏感肿瘤的一种治疗选择。